Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal prophylaxis

Overview of attention for article published in Frontiers in immunology, September 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 42,935 followers.

"CAR T-cell therapy has revolutionized B-cell cancer treatment but might need antifungal prophylaxis. After Gilead's Yescarta caused CRS grade II and ICANS grade IV, Actemra (tocilizumab), anakinra, and steroids caused pulmonary aspergillosis...micafungin"

18 Oct 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal proph…

28 Sep 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal proph…

28 Sep 2023

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Invasive fungal infection after anti-CD19 CAR-T cell therapy. Implication for antifungal proph…

28 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.